Clinical Trial Update: Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of JTT-252 in Diabetes Mellitus was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• JTT-252 (JTT-252)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Diabetes Mellitus | Phase 1 | Status: TERMINATED